Page last updated: 2024-09-05

etravirine and Hepatitis B, Chronic

etravirine has been researched along with Hepatitis B, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clotet, B; Clumeck, N; Katlama, C; Nijs, S; Witek, J	1

Trials

1 trial(s) available for etravirine and Hepatitis B, Chronic

Article	Year
Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:11 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Hepatitis C Antibodies; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Male; Nitriles; Placebos; Pyridazines; Pyrimidines	2010

Article

Year

Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials.

The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:11

Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Hepatitis C Antibodies; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Male; Nitriles; Placebos; Pyridazines; Pyrimidines

2010